Mydriacyl (Tropicamide)

Tropicamide, the active ingredient in Mydriacyl, is an anticholinergic (muscarinic antagonist) presented as an ophthalmic solution for ocular use. It works by blocking muscarinic receptors in the iris sphincter muscle, producing rapid pupil dilation and cycloplegia, which facilitate detailed examination of the interior of the eye and certain intra‑ocular procedures.

GNH USA supplies Mydriacyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this essential ophthalmic agent for eye‑care professionals and research institutions.

Tropicamide is a mydriatic and cycloplegic agent used in ophthalmic practice to temporarily enlarge the pupil and paralyze accommodation.

- Diagnostic eye examinations: provides pupil dilation for thorough fundus evaluation. - Intraocular surgery: creates cycloplegia to relax accommodation during procedures. - Laser retinal therapy: facilitates access and safety during laser treatments.

Tropicamide may cause ocular discomfort or visual changes after administration.

Common Side Effects: - Transient stinging or burning sensation. - Blurred vision. - Photophobia (light sensitivity). - Redness of the eye. - Mild headache. - Temporary increase in tear production.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma. - Severe allergic reaction, including anaphylaxis. - Significant rise in intra‑ocular pressure. - Persistent mydriasis. - Systemic anticholinergic effects such as dry mouth or tachycardia.

Before using Mydriacyl, consider the following safety measures.

- Assess intra‑ocular pressure: avoid in patients with narrow‑angle glaucoma. - Check for hypersensitivity to anticholinergics: discontinue if reaction occurs. - Use the lowest effective concentration: limit exposure time. - Avoid concurrent ocular medications without guidance: potential additive effects. - Store at room temperature: keep in original container, protect from light and moisture.

Tropicamide can interact with other ocular or systemic agents; monitor accordingly.

Major Interactions (Avoid): - Concurrent use of other mydriatics: may cause excessive pupil dilation. - Systemic anticholinergic drugs: increase risk of systemic anticholinergic effects.

Moderate Interactions (Monitor Closely): - Topical ocular anesthetics: may alter absorption. - Beta‑blocker eye drops: potential additive cardiovascular effects. - Inhaled anticholinergics for COPD: monitor for additive systemic anticholinergic load.